Haemonetics Corporation (HAE)

Receivables turnover

Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019
Revenue (ttm) US$ in thousands 2,596,175 2,424,725 2,393,776 2,373,078 2,323,237 1,114,154 1,068,622 1,011,034 987,485 954,649 935,251 904,840 862,112 882,733 901,332 944,412 989,857 1,000,660 989,046 978,061
Receivables US$ in thousands 206,562 211,611 174,249 177,117 179,142 181,100 159,376 127,555 146,939 141,533 141,094 165,207 170,753 176,535 163,339
Receivables turnover 12.57 11.46 13.74 13.40 12.97 6.15 6.20 6.76 6.01 6.37 6.69 5.99 5.86 5.60 5.99

March 31, 2024 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $2,596,175K ÷ $206,562K
= 12.57

The receivables turnover ratio measures how efficiently a company is able to collect its accounts receivable during a certain period. A higher receivables turnover ratio suggests that a company is collecting its outstanding receivables more quickly, which is generally a positive indicator of liquidity and efficiency.

Analyzing the receivables turnover ratio of Haemonetics Corporation over the past few quarters reveals some fluctuations. The company experienced a significant increase in receivables turnover from 6.15 in Dec 31, 2022, to 12.97 in Mar 31, 2023, indicating a notable improvement in the efficiency of collecting receivables. However, this ratio dropped to 6.20 in Mar 31, 2022, before increasing again to 13.40 in Jun 30, 2023.

On average, the receivables turnover ratio for Haemonetics Corporation has been relatively stable over the past few quarters, with an average turnover of around 10-12 times annually. This suggests that the company has been moderately effective in managing its accounts receivable and collecting payments from customers.

It is worth noting that the receivables turnover ratio can be influenced by various factors such as industry norms, credit policies, and economic conditions. Further analysis could be conducted to understand the specific reasons behind the fluctuations in Haemonetics Corporation's receivables turnover and to assess the overall impact on the company's financial performance and liquidity position.


Peer comparison

Mar 31, 2024